top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Antibody-Drug Conjugates and Immunotoxins : From Pre-Clinical Development to Therapeutic Applications / / edited by Gail Lewis Phillips
Antibody-Drug Conjugates and Immunotoxins : From Pre-Clinical Development to Therapeutic Applications / / edited by Gail Lewis Phillips
Edizione [1st ed. 2013.]
Pubbl/distr/stampa New York, NY : , : Springer New York : , : Imprint : Humana, , 2013
Descrizione fisica 1 online resource (369 p.)
Disciplina 615.37
615.373
Altri autori (Persone) PhillipsGail Lewis
Collana Cancer Drug Discovery and Development
Soggetto topico Cancer
Medicine - Research
Biology - Research
Immunospecificity
Cancer Biology
Biomedical Research
Adaptive Immunity
ISBN 1-283-93413-2
1-4614-5456-5
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Antibody Directed Delivery for Treatment of Cancer: Antibody Drug Conjugates and Immunotoxins -- Antibody-Drug Conjugate Development -- Components of ADC Development: Assay Methodologies and Challenges -- Clinical Pharmacology Strategies in the Development of Antibody-Drug Conjugates -- Predictive Biomarkers for Antibody-Drug Conjugates -- Factors Involved in the Design of Cytotoxic Payloads for Antibody-Drug Conjugates -- Linker Technology and Impact of Linker Design on ADC Properties -- Antibody-drug conjugates for the treatment of B-cell malignancies -- Targeting CD19 with SAR3419, an anti-CD19-Maytansinoid Conjugate for the Treatment of B Cell Malignancies -- Brentuximab Vedotin (SGN-35) for CD30 Positive Malignancies -- Trastuzumab Emtansine (T-DM1) for the Treatment of HER2-Positive Cancer -- CDX-011 (Glembatumumab Vedotin, CR011-vcMMAE) -- Case Study: An Antibody-Drug Conjugate Targeting MUC16 for Ovarian Cancer -- EphA2 Immunoconjugate -- Anti-PSMA Antibody-Drug Conjugates -- Targeting CD56 (NCAM)-expressing Neoplasms with Lorvotuzumab Mertansine -- Studies on the Metabolism of Antibody-Drug Conjugates -- Design, Development and Characterization of Recombinant Immunotoxins Targeting HER2/neu -- The Preclinical and Clinical Evaluation of VB6-845: An Immunotoxin with a De-Immunized Payload for the Systemic Treatment of Solid Tumors -- Index.
Record Nr. UNINA-9910437996003321
New York, NY : , : Springer New York : , : Imprint : Humana, , 2013
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Emerging contaminants of concern / / Alandra Kahl
Emerging contaminants of concern / / Alandra Kahl
Autore Kahl Alandra
Pubbl/distr/stampa New York : , : Momentum Press, Engineering, , [2019]
Descrizione fisica 1 online resource (180 pages)
Disciplina 615.373
Collana Environmental Engineering Collection
Soggetto topico Toxins
Environmental toxicology
Soggetto genere / forma Electronic books.
ISBN 1-947083-45-7
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910467360603321
Kahl Alandra  
New York : , : Momentum Press, Engineering, , [2019]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Emerging contaminants of concern / / Alandra Kahl
Emerging contaminants of concern / / Alandra Kahl
Autore Kahl Alandra
Pubbl/distr/stampa New York : , : Momentum Press, Engineering, , [2019]
Descrizione fisica 1 online resource (180 pages)
Disciplina 615.373
Collana Environmental Engineering Collection
Soggetto topico Toxins
Environmental toxicology
ISBN 1-947083-45-7
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910793261803321
Kahl Alandra  
New York : , : Momentum Press, Engineering, , [2019]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Emerging contaminants of concern / / Alandra Kahl
Emerging contaminants of concern / / Alandra Kahl
Autore Kahl Alandra
Pubbl/distr/stampa New York : , : Momentum Press, Engineering, , [2019]
Descrizione fisica 1 online resource (180 pages)
Disciplina 615.373
Collana Environmental Engineering Collection
Soggetto topico Toxins
Environmental toxicology
ISBN 1-947083-45-7
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910825238703321
Kahl Alandra  
New York : , : Momentum Press, Engineering, , [2019]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Microbial toxins / editors Samuel J. Ajl ... [et al.]
Microbial toxins / editors Samuel J. Ajl ... [et al.]
Pubbl/distr/stampa New York ; London, : Academic press, 1970-1972
Descrizione fisica Volumi : ill. ; 24 cm
Disciplina 615.373
Soggetto non controllato Tossine microbiche
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910772397703321
New York ; London, : Academic press, 1970-1972
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins / / edited by Ulf Grawunder, Stefan Barth
Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins / / edited by Ulf Grawunder, Stefan Barth
Edizione [1st ed. 2017.]
Pubbl/distr/stampa Cham : , : Springer International Publishing : , : Imprint : Springer, , 2017
Descrizione fisica 1 online resource (XI, 181 p. 57 illus., 39 illus. in color.)
Disciplina 615.373
Collana Milestones in Drug Therapy
Soggetto topico Pharmacology
Immunoglobulins
Chemotherapy
Cancer - Research
Oncology
Pharmacology/Toxicology
Antibodies
Pharmacotherapy
Cancer Research
ISBN 3-319-46877-4
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Chemical Assembly of Antibody-Drug Conjugates -- Pre-clinical evaluation of ADCs delivering highly potent pyrrolobenzodiazepine (PBD) dimers -- Stable and homogeneous drug conjugation by sequential bis-alkylation at disulfide bonds using bis-sulfone reagents -- Calicheamicin antibody-drug conjugates for liquid- and solid tumor indications -- Enzyme-based strategies to generate site-specifically conjugated Antibody Drug Conjugates -- Substance P – Saporin for the Treatment of Intractable Pain -- Recombinant immunotoxins for Chronic Inflammatory Disease -- BL22: A milestone in targeting CD22.
Record Nr. UNINA-9910253931703321
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2017
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Perspectives in toxicology / edited by Alan W. Bernheimer
Perspectives in toxicology / edited by Alan W. Bernheimer
Pubbl/distr/stampa New York : Wiley, 1977
Descrizione fisica XIII, 204 p. : ill. ; 26 cm
Disciplina 615.373
Collana Developments in medical microbiology and infectious diseases
Soggetto non controllato Batteri
ISBN 0471018554
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-990009189440403321
New York : Wiley, 1977
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Plant toxin analysis / edited by H. F. Linskens and J. F. Jackson ; contributors J. T. Arnason
Plant toxin analysis / edited by H. F. Linskens and J. F. Jackson ; contributors J. T. Arnason
Pubbl/distr/stampa Berlin [etc.] : Springer, c1992
Descrizione fisica XXV, 389 p. ; 24 cm.
Disciplina 615.373
Collana Modern methods of plant analysis
Soggetto topico Tossine vegetali
ISBN 0-387-52328-6
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNIBAS-000014956
Berlin [etc.] : Springer, c1992
Materiale a stampa
Lo trovi qui: Univ. della Basilicata
Opac: Controlla la disponibilità qui
Resistance to Immunotoxins in Cancer Therapy / / edited by Rama Shanker Verma, Benjamin Bonavida
Resistance to Immunotoxins in Cancer Therapy / / edited by Rama Shanker Verma, Benjamin Bonavida
Edizione [1st ed. 2015.]
Pubbl/distr/stampa Cham : , : Springer International Publishing : , : Imprint : Springer, , 2015
Descrizione fisica 1 online resource (259 p.)
Disciplina 615.373
Collana Resistance to Targeted Anti-Cancer Therapeutics
Soggetto topico Cancer - Research
Drug resistance
Pharmacology
Cancer Research
Drug Resistance
Pharmacology/Toxicology
ISBN 3-319-17275-1
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Preface ; About the Editor ; Contents; Contributors; Chapter-1; Targeted Cancer Therapy: History and Development of Immunotoxins; 1.1 Introduction; 1.2 Chemotherapy; 1.3 Cancer Immunotherapy; 1.3.1 Antibodies in Cancer Therapy; 1.3.2 Tumor Antigens; 1.3.3 Antibodies for the Clinic; 1.3.4 Antibodies as Carriers; 1.4 Immunotoxins in Cancer Therapy; 1.4.1 Targeting Moiety; 1.4.2 Toxins in Cancer Immunotherapy; 1.5 Construction of an Immunotoxin; 1.6 Internalization and Cytotoxic Activity of Immunotoxins; 1.7 Immunotoxins in Clinical Study; 1.8 Conclusions; References; Chapter-2
Immunotoxins, Resistance and Cancer Stem Cells: Future Perspective2.1 Introduction; 2.2 Factors Responsible for Cancer Resistance; 2.2.1 Gene Mutations in Signalling Pathways; 2.2.2 Drug Transporters; 2.2.3 Tumor Microenvironment and Accessibility; 2.3 Resistance to Immunotoxins; 2.3.1 Dysfunctional Apoptotic Pathways; 2.3.2 ABC Transporters; 2.3.3 Lysosomal Degradation; 2.3.4 Other Factors; 2.4 Cancer Stem Cells and Resistance; 2.4.1 Drug Efflux; 2.4.2 Detoxification and Cellular Repair; 2.4.3 DNA Repair and Modification; 2.4.4 Survival Pathways; 2.4.5 Autophagy and EMT; 2.4.6 Quiescence
2.4.7 Microenvironment2.5 Strategies Used to Overcome Resistance; 2.5.1 Inhibitors of Anti-apoptotic Proteins; 2.5.2 Blocking Membrane Drug Transporters; 2.5.3 Delivery and Intracellular Trafficking; 2.5.4 Inhibition of DNA Repair and Telomerase Activity; 2.5.5 Combination Therapy; 2.5.6 Nanotechnology; 2.5.7 Other Novel Strategies; 2.6.1 Targeting Signaling Pathways in CSC's; 2.6 Targeting Cancer Stem Cells; 2.6.2 Targeting Apoptosis and Cellular Repair Mechanisms in CSC's; 2.6.3 Targeting Autophagy and Microenvironment in CSC's; 2.6.4 Targeting Membrane Transporters and CSC Surface Markers
2.7 ConclusionReferences; Chapter-3; Factors that Determine Sensitivity and Resistances of Tumor Cells Towards Antibody-Targeted Protein Toxins; 3.1 Introduction; 3.2 Intoxication Pathways Define Determinants for Sensitivity and/or Resistances of Tumor Cells Towards Immunotoxins; 3.3 Step 1-Access to Target Cells: Immunogenicity can be a Relevant Factor for Immunotoxin Therapy; 3.4 Step 2-Target Cell Binding: Loss or Reduction of Target Antigens Reduce Sensitivity of Tumor Cells Towards Targeted Toxins
3.5 Step 3-Entry of Toxins into Cells: Loss of Processing Enzymes and Modulation of Vesicular Compartments Reduce Toxin Activity in Cultured Cells3.6 Step 4-ADP-Ribosylation of eEF2: Reduced or Altered Expression of Diphthamide Synthesis Genes is Associated with Immunotoxin Resistances; 3.7 Step 5-Signaling and Apoptosis: Protective Factors and Pathways can Reduce Toxin Sensitivity; 3.8 Conclusions and Outlook; References; Chapter-4; Cell Signaling and Resistance to Immunotoxins; 4.1 Introduction; 4.2 Conceptual Considerations on Cellular Immunotoxin Resistance
4.2.1 Alteration of Immunotoxin Resistance via Modulation of Caspase Activation Pathways
Record Nr. UNINA-9910298266803321
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2015
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Toxins in Drug Discovery and Pharmacology / / edited by Steve Peigneur
Toxins in Drug Discovery and Pharmacology / / edited by Steve Peigneur
Pubbl/distr/stampa Basel, Switzerland : , : MDPI - Multidisciplinary Digital Publishing Institute, , 2018
Descrizione fisica 1 online resource (316 pages)
Disciplina 615.373
Soggetto topico Pharmacology
Toxins
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910597903603321
Basel, Switzerland : , : MDPI - Multidisciplinary Digital Publishing Institute, , 2018
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui